Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACOMITINIB vs DANAPAROID: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACOMITINIB vs DANAPAROID: Safety Overview

Metric DACOMITINIB DANAPAROID
Total FAERS Reports 682 170
Deaths Reported 325 67
Death Rate 47.7% 39.4%
Hospitalizations 168 75
Average Patient Age 64.0 yrs 63.4 yrs
% Female Patients 52.0% 63.1%
FDA Approval Date Sep 27, 2018 Dec 24, 1996
Manufacturer Pfizer Laboratories Div Pfizer Inc N/A
Route ORAL N/A
Marketing Status Prescription Discontinued